AVAtefeh Verdi

Atefeh Verdi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Atefeh Verdi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Nanomicelle curcumin improves oxidative stress, inflammatory markers, and assisted reproductive techniques outcomes in endometriosis cases: a randomized clinical trial

    by Rahil Jannatifar, Elham Asa, Ebrahim Cheraghi, Atefeh Verdi

    We studied the effect nanomicelle curcumin on oxidative stress markers, pro-inflammatory cytokines, and assisted reproductive techniques (ART) outcomes in endometriosis cases. This randomized controlled trial was conducted on 50 women with endometriosis at the age of 25–35 candidate for ART referred to Roya Infertility Center in Qom, Iran, 2022. The participants were allocated to intervention (n = 25) and control (n = 25) groups by the blocked randomization method. Nanomicelle curcumin with a dose of 120 mg per day was given to the intervention group twice a day for 10 weeks, and the placebo with the same dose was given to the control group. Follicular fluid (FF) samples were collected from women with endometriosis stage III/IV undergoing ART. Antioxidant enzyme (MDA, SOD, CAT, and TAC) and pro-inflammatory cytokines (IL-8 and TNF-a) were tested. ART results such as (number of oocyte received, high-quality embryo, and pregnancy outcomes) were compared between two groups. Increased serum levels of TAC, CAT, and SOD were observed after nanomicelle curcumin treatment. Furthermore, FF levels of MDA, IL-8, and TNF-a reduced significantly after treatment in nanomicelle curcumin. Nanomicelle curcumin supplementation led to an improved number of oocytes retrieved, number of mature (MII) oocytes, fertilization, cleavage, and high-quality embryos. Nanomicelle curcumin treatment can modulate stress oxidative and inflammation in endometriosis-induced infertile patients. ART outcomes also improved after nanomicelle curcumin therapy. Our results suggest that nanomicelle curcumin can be a therapeutic target for infertile patients with endometriosis.


  • The effect of rhFSH on Sperm DNA Fragmentation and sperm parameters in Oligozoospermia Infertile Men

    by Atefeh Verdi, Seyedeh Saeideh Sahraei, Elham Asa, Rahil Jannatifar, Mohamad Bagher Masaeimanesh

    Background: One of the main causes of male infertility is the negative effects of oxidative stress. Follicle-stimulating hormone (FSH) plays an essential role in spermatogenesis, as well as in the maintenance of sperm DNA integrity. This study aimed to determine whether the recombinant human follicle-stimulating hormone (rhFSH) treatment of sperm parameters could positively affect sperm DNA and oxidative DNA fragmentation in oligozoospermia infertile men. Materials and Methods: This interventional study was carried out on a sample of 50 oligozoospermia infertile men. To this end, sperm DNA fragmentation and ROS as an oxidative stress marker were measured before and after treatment with the rhFSH sperm parameters. Results: The sperm parameters (concentration, mobility, and morphology) were significantly different in the oligozoospermia infertile patients before and after the rhFSH treatment (p<0.05). Moreover, sperm DNA fragmentation had a significant decrease in the patients after the FSH treatment (p<0.05). In addition, the ROS level in sperm, and the malondialdehyde level of seminal plasma significantly decreased after the treatment (P<0.05). Conclusion: The findings indicated that the rhFSH treatment significantly improved the sperm parameters. Further, the treatment led to a meaningful reduction of sperm DNA fragmentation and oxidative stress in the oligozoospermia infertile patients. Similarly, the malondialdehyde concentration markedly decreased in correlation with DNA fragmentation after the rhFSH treatment.